Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1373 results about "Cystine" patented technology

Cystine is the oxidized dimer form of the amino acid cysteine and has the formula (SCH₂CH(NH₂)CO₂H)₂. It is a white solid that is slightly soluble in water. It serves two biological functions: a site of redox reactions and a mechanical linkage that allows proteins to retain their three-dimensional structure.

Novel recombinant proteins with N-terminal free thiol

InactiveUS20050170457A1Extended half-lifeIncreases circulating serum half-lifePeptide/protein ingredientsTissue cultureCysteine thiolateHalf-life
The present invention relates to novel modified proteins having N-terminal free thiols that can be produced by recombinant methods and are ready for further chemical derivatization. In particular, the invention relates to erythropoietin conjugate compounds having altered biochemical, physiochemical and pharmacokinetic properties. More particularly, one embodiment of the invention relates to erythropoietin conjugate compounds of the formula: (M)n-X-A-cys-EPO   (I) where EPO is an erythropoeitin moiety selected from erythropoietin or an erythropoietin variant having at least one amino acid different from the wild-type human EPO, or any pharmaceutical acceptable derivatives thereof having biological properties of causing bone marrow cells to increase production of red blood cells; cys represents the amino acid cysteine and occurs at position −1 relative to the amino acid sequence of the erythropoietin moiety; A indicates the structure of the residual moiety used to chemically attach X to the thiol group of −1Cys; X is a water soluble polymer such as a polyalkylene glycol or other polymer; M is an organic molecule (including peptides and proteins) that increases the circulating half-life of the construct; and N is an integer from 0 to 15.
Owner:CENTOCOR

Cysteine engineered Anti-muc16 antibodies and antibody drug conjugates

Cysteine engineered anti-MUC16 antibodies are engineered by replacing one or more amino acids of a parent anti-MUC16 antibody with non cross-linked, reactive cysteine amino acids. Methods of design, preparation, screening, and selection of the cysteine engineered anti-MUC16 antibodies are provided. Cysteine engineered anti-MUC16 antibodies (Ab) are conjugated with one or more drug moieties (D) through a linker (L) to form cysteine engineered anti-MUC16 antibody-drug conjugates having Formula I:Ab-(L-D)p   Iwhere p is 1 to 4. Diagnostic and therapeutic uses for cysteine engineered antibody drug compounds and compositions are disclosed.
Owner:GENENTECH INC

Cysteine protease inhibitor

PCT No. PCT / JP96 / 00840 Sec. 371 Date May 20, 1996 Sec. 102(e) Date May 20, 1996 PCT Filed Mar. 29, 1996 PCT Pub. No. WO96 / 30395 PCT Pub. Date Oct. 3, 1996A pharmaceutical composition for inhibiting cysteine protease which comprises a compound of the formula: wherein R1 is a hydrogen atom or an acyl group; R2, R3 and R4, same or different, are a bond, an amino acid residue or a group of the formula:-Y-R5-in which R5 is a group resulting from imino group removal from an amino acid residue; Y is -O-, -S- or -NR6- in which R6 is a hydrogen atom or a lower alkyl group; A is Z is a hydrogen atom, an acyl group or an optionally substituted hydrocarbon group; n is 1 or 2; provided that when n is 1, then A is and Y is -S- or -NR6-, and, at least one of R2, R3 and R4 is the formula -Y-R5-, provided that when further all Y are -NR6-, at least one of the amino acid residues is not bound to amhydrogen atom at the alpha -carbon thereof but substituted via carbon; provided that when n is 2 and Z is an aldehyde group, then R1 is an acyl group having 6 or more carbon atoms; provided that when n is 2 and A is, then at least one of R2, R3 and R4 is the formula -Y-R5-; or an ester or a salt thereof, and a pharmaceutically acceptable carrier.
Owner:TAKEDA PHARMACEUTICALS CO LTD

Black garlic, process and device for fermenting same

The invention discloses black garlic, a process and a device for fermenting the same, which overcomes technical defects of the prior product, processing method and processing device. The black garlic is integral in bulk, dry in outer peel and easy to peel. Garlic cloves are in preserved fruit paste shape, are free from pungent taste, have jelly taste, taste good and are easy to preserve. Every 100 grams of ripening black garlic contains 140 milligrams of isoleucine, 250 milligrams of leucine, 170 milligrams of lysine, 160 milligrams of cystine, S-allyl cysteine and polyphenol of which the content is 22 times that of raw garlic, 36 milligrams of sodium, 930 milligrams of potassium, 52 milligrams of magnesium and 13 milligrams of calcium. The black garlic has the advantages of low heavy-metal content, no pesticide residue and no additive. The fermenting process comprises the steps of taking integral garlic as raw material, initially washing the raw material with clear water, soaking the raw material in brine, placing the raw material in a tray, fermenting, steaming and baking the raw material, performing aging treatment, sterilizing and disinfecting the obtained product, and packing the obtained product in vacuum or with nitrogen. The fermenting process has the advantages of adopting mineral water vapor and discharging air in the whole process, along with few links and low cost. The fermenting device is heated by a steam boiler, has a humidifying vapor pipe, and uses all-wooden fermentation frame and a container.
Owner:DALIAN HUAGU GARLIC

Preparation method and application of selenium-enriched cadmium-resistant foliar fertilizer special for rice

InactiveCN105819986AReduce usageEliminate the risk of poisoningFertilising methodsNitrogenous fertilisersSucroseSilicic acid
The invention provides a preparation method and application of a selenium-enriched cadmium-resistant foliar fertilizer special for rice .The preparation method of the selenium-enriched cadmium-resistant foliar fertilizer special for the rice comprises the following steps that sodium selenite, zinc sulfate, manganese sulfate and ferrous sulfate are dissolved in water and prepared into an original mother liquid, wherein the concentration of sodium selenite ranges from 30 g/l to 60 g/l; the original mother liquid is mixed with an amino acid solution of which the mass concentration ranges from 15% to 20%, shaking chelating is conducted, and a chelating liquid is obtained; the chelating liquid and a single silicic acid aqueous solution are mixed to be uniform to be prepared into a mixed liquid; sodium alkyl benzene sulfonate is added, the mixture and filtrate obtained through saccharose alcohol fermentation are stirred at 25 DEG C to 35 DEG C for secondary chelating, and the selenium-enriched cadmium-resistant foliar fertilizer special for the rice is obtained .By means of the preparation method and application of the selenium-enriched cadmium-resistant foliar fertilizer special for the rice, 90% or above of inorganic selenium is converted into organic selenium such as selenomethionine and selenocystine, the poisoning risk is eliminated, the absorption conversion rate of selenium is increased, the raw material amount is reduced, the cost is reduced, and the rice has a good cadmium-resistant property.
Owner:AGRI RESOURCE & ENVIRONMENT RES INST GUANGXI ACADEMY OF AGRI SCI

Colorimetric and Fluorometric Determination of Homocysteine and Cysteine

Colorimetric and fluorometric methods are disclosed for the rapid, accurate, selective, and inexpensive detection of homocysteine, or of homocysteine and cysteine, or of cysteine. The methods may be employed with materials that are readily available commercially. The novel methods are selective for homocysteine, for cysteine, or for total homocysteine and cysteine, and do not cross-react substantially with chemically-related species such as glutathione. The homocysteine-selective method does not have substantial cross-reactivity to the very closely related species cysteine. The cysteine-selective method does not have substantial cross-reactivity to the very closely related species homocysteine. The methods may be used, for example, in a direct assay of human blood plasma for homocysteine levels.
Owner:BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRI & MECHANICAL COLLEGE

Cement grinding aid and preparation method thereof

The invention discloses a cement grinding aid. The cement grinding aid comprises the following components in percentage by weight: 8 to 20 percent of triethanolamine, 0 to 10 percent of triisopropanolamine, 8 to 20 percent of diol byproduct, 0 to 10 percent of synthetic glycerine, 0 to 25 percent of molasses, 0 to 5 percent of calcium lignosulfonate, 0 to 15 percent of polyurethane, 0 to 10 percent of cystine, 3 to 5 percent of sorbitol, 5 to 10 percent of sodium carboxymethylcellulose, 0 to 5 percent of citric acid, 0 to 5 percent of silica powder, 0 to 5 percent of fly ash and the balance of water. The invention also discloses a preparation method of the cement grinding aid. The grinding aid can effectively improve the equipment-hour yield of a cement grinding mill, reduce energy consumption and remarkably improve cement performance, does not have adverse side effects on cement, reduces the using amount of cement clinkers by 4 to 10 percent, improves the equipment-hour yield of cement production by 6 to 10 percent, and has a good effect. The method has a unique process, a part of raw materials are treated by ultrasound, and the prepared grinding aid has high performance.
Owner:CHINA UNITED CEMENT LUNAN

Clear liquid fermentation medium for clostridium butyricum and fermentation culture method thereof

The invention relates to a clear liquid fermentation medium for clostridium butyricum. The clear liquid fermentation medium, the pH value of which is 7-8, is made from glucose, tryptone, a yeast extract powder, ammonium sulfate, sodium bicarbonate, a maize liquid powder and the like. The clear liquid fermentation medium for clostridium butyricum contains metal salts for promoting the growth of gemma, wherein the metal salts are manganese sulfate, magnesium sulfate and ferrous sulphate. The enrichment medium of the clear liquid fermentation medium for clostridium butyricum contains yeast extract, beef extract, tryptone, glucose, soluble starch, sodium chloride, sodium acetate trihydrate, cysteine hydrochloride, methylene blue at the concentration of 0.5% and distilled water; and the pH is adjusted to 7.1. A fermentation culture method of the clear liquid fermentation medium for clostridium butyricum comprises the following steps of: glycerin tube refrigerated strain activation, heating and optimization, Erlenmeyer flask first-order seed culture, liquid fermentation and spray drying. The production of clostridium butyricum has advantages of simple operation, high amount of zymocyte, high gemma yield, simple post-treatment, less impurities in a bacterial powder sample and high amount of effective live bacteria, and saves cost at large.
Owner:HUAZHONG AGRI UNIV

Adjuvant immune therapy in the treatment of solid tumors through modulation of signaling pathways following engagement of humoral and cell mediated responses

The invention combines a novel combination with two especially important aspects: first, the invention proposes to simultaneously stimulate response in white blood cells and a patient's tumor cells with a mitogen-challenging compound, preferably a lectin, in the preferred mode the selected lectin being phytohemagglutin ("PHA"), and second, to generate heat shock protein. A method of treatment is set out. The method of manufacturing proposed utilizes a system calculated to better insure sterility and streamline production of the cytokine modulator. A method of testing in conjunction with the therapy is also claimed utilizing clinical assessment of disease activity, patient performance status, and quality of life questionnaire. Should efficacy of a treatment fall off, particularly because of mutation or adaption, the composition and method may be re- applied. The invention is not limited to humans, but is also applicable to mammals. The composition is usable as a stand-alone composition, but preferably is used in conjunction with standard therapy such as radiation, chemotherapy or surgery, particularly surgical therapy, and in conjunction with the administration of cystine, as later defined, to enhance immune system competency.
Owner:KINDNESS GEORGE +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products